Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Borrow rate
0.00%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.2M | $9.9M | $7.9M | $9.1M | $8.8M | $10.1M | $8.3M | $7.7M |
| Cost of revenue | $14.4M | $13.0M | $6.5M | $6.3M | $6.1M | $6.7M | $5.6M | $5.6M |
| Gross profit | $4.8M | −$3.1M | $1.4M | $2.9M | $2.6M | $3.4M | $2.7M | $2.0M |
| Gross margin | 24.8% | -30.9% | 17.5% | 31.4% | 29.9% | 33.8% | 32.1% | 26.2% |
| R&D | $15.5M | $11.3M | $6.0M | $5.7M | $5.7M | $5.9M | $4.4M | $4.5M |
| Operating income | −$50.7M | −$42.6M | −$22.1M | −$19.4M | −$17.4M | −$18.1M | −$16.0M | −$16.6M |
| EBITDA | −$49.1M | −$41.0M | −$20.6M | −$16.4M | −$16.4M | −$17.4M | −$15.8M | −$16.3M |
| Net income | −$56.1M | −$48.7M | −$27.6M | −$19.8M | −$19.8M | −$20.7M | −$17.4M | −$18.3M |
| Net margin | -292.1% | -490.6% | -348.2% | -216.3% | -226.3% | -204.4% | -210.6% | -239.4% |
| EPS (diluted) | -283474.75 | -175927.80 | -7736.66 | -818.60 | -120.80 | -65.79 | -41.83 | -23.31 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $18M | $-0.74 | $-0.74–$-0.74 | 1 |
| 2027 | $22M | $-0.43 | $-0.43–$-0.43 | 1 |
| 2028 | $28M | $-0.25 | $-0.25–$-0.25 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds AVGR.
No tracked institution reports a position in AVGR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-09-13 | 1-for-15reverse |
| 2022-03-15 | 1-for-20reverse |
| 2019-06-24 | 1-for-10reverse |
| 2018-01-31 | 1-for-40reverse |
No one on the platform has traded AVGR yet.
| $221 |
| — |
| NAYANAYA Biosciences, Inc. | $2.20 | +8.37% | $1M | — |
| NBSENeuBase Therapeutics, Inc. | $0.38 | -1.56% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 2.0× historical median P/S.
Fair value ≈ $30.09 · price $0.47 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$AVGR I still have a short position 🤣 I believe the dissolution is finally getting close to done and shareholders can finally get their tax loss for the year ;)
View on StockTwits ↗$AVGR holyphukk I remember trading this 4-5 years ago, and it's still getting clobbered by the hedgies. Reminds me of the David Michery scams like Mullen. Good luck folks. I thought it would be a great company back in 2020 when they were releasing fantastic updates about their patented intravascular surgical devices, but NOPE. Obliterated relentlessly. Oblivion.
View on StockTwits ↗@laurent_fr I have 10,000 $AVGR shares. Interested to sell. Regards
View on StockTwits ↗$AVGR Quick question for the community — are there any long shareholders here who might be interested in matching with us on the short side? If that’s the case, feel free to reach out or make yourselves known. Would be great to connect.
View on StockTwits ↗$AVGR Just looking back, noticed the symbol. Dumped it a long time ago, and like many lost $$. I did think they had potential, but guess that was my own dream of success. Itc seemed like a logical company with a chance, but obviously everything went down the tubes. Management still receiving salaries like so many bad corporations?
View on StockTwits ↗$AVGR What are these CROOKS - STILL up to now? After swindling investors out of over $450M, and liquidating the US Corporate Facilities in California after going into partnership with Zylox-Tonbridge (China!) They were pointing to listing a fake SHELL company in Texas called "Lumivascular" Now the current 2026 Avinger website is representing itself as "AVINGER | FLEX" - Where are the Company Financials? - How much money are the making from the Zylox-Tonbridge partnership? - They claimed to be FastTracking approval for Clinical use of Avinger’s products in China...Are they performing procedures for profit? - Have they received a CAD-IDE Indication for there Cathater's, that they were touting as being very promising, and would be HIGHLY PROFITABLE? - Are the products still being sold and used in the USA and MANY other regions they claimed to have Representation in? JUST WHAT THE FUCK IS GOING ON! It been a FAKE SHELL GAME the whole time to Lucratively STEAL Money for themselves!
View on StockTwits ↗@Wayne_L Agreed. Researchers should never run companies. $AVGR Lost out big time to this. Similarly awesome tech, bk in the end.
View on StockTwits ↗$AVGR AVINGER... They ARE and HAVE BEEN the entire time since inception MANIPULATING CROOKS and THIEVES, LYING an MISLEADING Shareholders! - They are STILL in partnership with the Chinese Company "Zylox-Tonbridge" for R&D, and Production for Groundbreaking advances in CAD, as well as the entire PAD Product Line ...but completely SILENT ! - Their website since Oct points to a SHADOW Company in Texas called " Lumivascular" (a few months ago a link would direct you to a crude website, but now it's a looping link back to Avinger) WTF ??? !!! - ANY S.H. left after enduring 99.9% Loses has NO WAY to trade/sell out! - The "Liquidation" was just a RUSE to get rid of unwanted manufacturing equipment, office equipment and facility in California. THIEVES, THIEVES, THIEVES!!! WHERE ARE THE LAWSUITS ??? THEY NEED TO BE JAILED, with Monitary Claw-Back's as Restitution! AVINGER is still a corporation in business after stealing +$450 M from shareholders, with No accountability!
View on StockTwits ↗$AVGR Why is this stock still listed? Did they finish liquidation proceedings? What is left to do?
View on StockTwits ↗$AVGR nobody can sell this I wanna sell how can we sell
View on StockTwits ↗$AVGR Are these crooks still eating lobster or what's the story?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.